Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Madec

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
European Journal of Endocrinology|July 5, 2007
Contrasting cellular and humoral autoimmunity associated with latent autoimmune diabetes in adultsA Mayer, N Fabien, M C Gutowski, et al.
Clinical Endocrinology|September 1, 1984
Thyroid stimulating antibodies: an aid to the strategy of treatment of Graves' disease?A M Madec, M C Laurent, Y Lorcy, et al.
Clinical and Experimental Immunology|December 18, 2003
Modulation of antigen presentation by autoreactive B cell clones specific for GAD65 from a type I diabetic patientJ P Banga, J K Moore, N Duhindan, et al.
Diabetologia|August 22, 2000
Two amino acids in glutamic acid decarboxylase act in concert for maintenance of conformational determinants recognised by Type I diabetic autoantibodiesT I Tree, N G Morgenthaler, N Duhindan, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1990
Antithyroid drugs and Graves' disease: a prospective randomized evaluation of the efficacy of treatment durationH Allannic, R Fauchet, J Orgiazzi, et al.
Clinical and Experimental Immunology|October 23, 2004
Multiplicity of the antibody response to GAD65 in Type I diabetesL K Gilliam, K A Binder, J P Banga, et al.
Immunology Letters|August 11, 1998
Peptide specificity of high-titer anti-glutamic acid decarboxylase (GAD)65 autoantibodiesF Rharbaoui, C Granier, M Kellou, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|May 26, 2004
Fetal and neonatal thyroid function in relation to maternal Graves' diseaseMichel Polak, Isabelle Le Gac, Edith Vuillard, et al.
Diabetologia|April 19, 2005
Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk of developing type 1 diabetesM Schlosser, J P Banga, A M Madec, et al.
Journal of Molecular Biology|May 1, 1999
High-resolution autoreactive epitope mapping and structural modeling of the 65 kDa form of human glutamic acid decarboxylaseH L Schwartz, J M Chandonia, S F Kash, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
European Journal of Endocrinology|July 5, 2007
Contrasting cellular and humoral autoimmunity associated with latent autoimmune diabetes in adultsA Mayer, N Fabien, M C Gutowski, et al.
Clinical Endocrinology|September 1, 1984
Thyroid stimulating antibodies: an aid to the strategy of treatment of Graves' disease?A M Madec, M C Laurent, Y Lorcy, et al.
Clinical and Experimental Immunology|December 18, 2003
Modulation of antigen presentation by autoreactive B cell clones specific for GAD65 from a type I diabetic patientJ P Banga, J K Moore, N Duhindan, et al.
Diabetologia|August 22, 2000
Two amino acids in glutamic acid decarboxylase act in concert for maintenance of conformational determinants recognised by Type I diabetic autoantibodiesT I Tree, N G Morgenthaler, N Duhindan, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1990
Antithyroid drugs and Graves' disease: a prospective randomized evaluation of the efficacy of treatment durationH Allannic, R Fauchet, J Orgiazzi, et al.
Clinical and Experimental Immunology|October 23, 2004
Multiplicity of the antibody response to GAD65 in Type I diabetesL K Gilliam, K A Binder, J P Banga, et al.
Immunology Letters|August 11, 1998
Peptide specificity of high-titer anti-glutamic acid decarboxylase (GAD)65 autoantibodiesF Rharbaoui, C Granier, M Kellou, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|May 26, 2004
Fetal and neonatal thyroid function in relation to maternal Graves' diseaseMichel Polak, Isabelle Le Gac, Edith Vuillard, et al.
Diabetologia|April 19, 2005
Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk of developing type 1 diabetesM Schlosser, J P Banga, A M Madec, et al.
Journal of Molecular Biology|May 1, 1999
High-resolution autoreactive epitope mapping and structural modeling of the 65 kDa form of human glutamic acid decarboxylaseH L Schwartz, J M Chandonia, S F Kash, et al.
Pageof 5